Table 2.
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |
NPR | ||||||
Tertile 1 | Reference | Reference | Reference | |||
Tertile 2 | 1.521 (0.991–2.335) | 0.055 | 0.946 (1.299–1.812) | 0.837 | 1.017 (0.575–1.800) | 0.953 |
Tertile 3 | 7.245 (4.525–11.600) | <0.001 | 7.839 (2.842–4.301) | 0.005 | 2.000 (1.041–3.843) | 0.037 |
Atrial fibrillation | 2.627 (1.353–5.102) | 0.004 | 2.514 (1.242–5.089) | 0.010 | ||
Large infarct volume | 7.839 (2.842–21.625) | <0.001 | 4.810 (1.679–13.780) | 0.003 | ||
Baseline NIHSS | 1.249 (1.175–1.329) | <0.001 | 1.256 (1.176–1.343) | <0.001 | ||
Anterior circulation | 4.133 (2.068–8.261) | <0.001 | ||||
Antiplatelet | 0.213 (0.109–0.417) | <0.001 |
Model 1 was adjusted for age and gender. Model 2 was adjusted for the variables in model 1 plus the factors that had already been established as predictors of HT, including diabetes mellitus, atrial fibrillation, systolic blood pressure, large infarct volume, baseline NIHSS, anticoagulant and thrombolysis. Model 3 was adjusted for all the variables in model 2 plus the factors that significantly differed between the HT groups on the univariate analysis, including coronary heart disease, anterior circulation and antiplatelet. NPR, neutrophil-to-platelet ratio; HT, hemorrhagic transformation; OR, odd ratio; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale.